NCT07430462Not yet recruiting
Home-Based Exergame Rehabilitation for Upper Limb Function in People With Multiple Sclerosis
Effectiveness and Feasibility of a Home-Based Exergame Rehabilitation Protocol for Upper Limb Function in Individuals With Multiple Sclerosis: A Randomized Controlled Pilot Trial
Source: ClinicalTrials.gov · Last updated 24 Feb 2026
Brief summary (registry, in English)
This randomized pilot clinical trial aims to evaluate the effectiveness, feasibility, and cost-effectiveness of a semi-autonomous upper-limb rehabilitation program based on therapeutic exergames in people with Multiple Sclerosis (MS). The intervention integrates intensive motor practice, multisensory feedback, and cognitively demanding tasks to enhance upper-limb function, dexterity, and patient autonomy. Participants will be randomly assigned to either an exergame-based home rehabilitation program with remote physiotherapist supervision or a dose-matched conventional home-based physiotherapy program. The primary outcome is upper-limb functionality measured by the Action Research Arm Test (ARAT). Secondary outcomes include motor function, manual ability, quality of life, usability, adherence, and digital performance metrics related to the execution of motor and cognitive tasks. Follow-up at 16 weeks will assess the sustainability of treatment effects. This study seeks to generate evidence on whether exergame-based rehabilitation can serve as an accessible, scalable, and patient-centered alternative to conventional home-based upper-limb rehabilitation for individuals with MS.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 11 Feb 2026
- Start date
- Apr 2026
- Primary completion date
- Sept 2026
- Lead sponsor
- Marina Castel Sánchez
- Diseases
- Multiple sclerosis
- NCT number
- NCT07430462
What you commit to
- Study type: Interventional
- Planned participants: 40
- From Apr 2026 to the primary completion date, Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Botulinum toxin treatment in the upper limb within the previous 6 months.
Other illness
- Acute illness, musculoskeletal injury, or pain interfering with the ability to perform the intervention exercises.
- Disruptive behavior or other conditions that significantly hinder participation in the rehabilitation program.
- Active epilepsy or any medical contraindication to physical exercise.
Other
- Uncompensated visual or hearing impairments that limit participation.
Who the study is looking for
- Age ≥ 18 years.
- Clinical diagnosis of Multiple Sclerosis with EDSS score between 2.0 and 6.5, with upper-limb involvement.
- Ability to maintain independent sitting and to stand with or without assistive devices.
- Upper-limb functional capacity between 11 and 54 points on the ARAT, indicating limited to substantial impairment.
- Cognitive ability to understand and follow simple instructions, demonstrated by a Mini-Mental State Examination score ≥ 23.
- Provision of written informed consent by the participant or legally authorized representative.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universidad Europea de Madrid Coordinator of this site? Confirm its status | Villaviciosa de Odón | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.